Your browser is no longer supported. Please, upgrade your browser.
Settings
EXAS [NASD]
Exact Sciences Corporation
Index- P/E- EPS (ttm)-4.98 Insider Own0.50% Shs Outstand171.98M Perf Week-10.38%
Market Cap13.88B Forward P/E- EPS next Y-3.29 Insider Trans-12.88% Shs Float171.13M Perf Month-18.80%
Income-811.80M PEG- EPS next Q-0.66 Inst Own91.20% Short Float7.01% Perf Quarter-29.07%
Sales1.76B P/S7.89 EPS this Y-777.40% Inst Trans1.72% Short Ratio7.97 Perf Half Y-31.65%
Book/sh20.10 P/B3.81 EPS next Y12.10% ROA-13.00% Target Price132.53 Perf Year-41.39%
Cash/sh6.72 P/C11.39 EPS next 5Y- ROE-24.10% 52W Range78.67 - 159.54 Perf YTD-42.19%
Dividend- P/FCF- EPS past 5Y-26.80% ROI-17.30% 52W High-51.99% Beta1.27
Dividend %- Quick Ratio2.10 Sales past 5Y106.80% Gross Margin75.00% 52W Low-2.64% ATR5.07
Employees4800 Current Ratio2.30 Sales Q/Q11.80% Oper. Margin-60.60% RSI (14)29.09 Volatility6.95% 5.79%
OptionableYes Debt/Eq0.64 EPS Q/Q28.00% Profit Margin-46.10% Rel Volume1.90 Prev Close80.57
ShortableYes LT Debt/Eq0.55 EarningsNov 02 AMC Payout- Avg Volume1.51M Price76.59
Recom1.60 SMA20-14.26% SMA50-17.52% SMA200-30.78% Volume2,860,335 Change-4.94%
Nov-03-21Downgrade Raymond James Strong Buy → Outperform $160 → $130
Jul-29-21Reiterated Stifel Buy $165 → $145
Jul-29-21Reiterated Oppenheimer Outperform $161 → $155
Jul-29-21Reiterated Canaccord Genuity Buy $185 → $160
Jul-29-21Reiterated BTIG Research Buy $155 → $145
Jun-15-21Initiated Raymond James Strong Buy $160
Jun-03-21Initiated Goldman Buy $160
May-25-21Initiated Wells Fargo Equal Weight $115
Jan-28-21Initiated Truist Buy $226
Oct-29-20Downgrade UBS Buy → Neutral $125 → $140
Oct-28-20Downgrade Citigroup Buy → Neutral $120 → $140
Oct-08-20Resumed BTIG Research Buy $140
Apr-02-20Initiated Evercore ISI Outperform $70
Jan-10-20Resumed BTIG Research Buy $127
Jan-07-20Initiated Citigroup Buy $120
Dec-13-19Initiated Dougherty & Company Buy $120
Nov-15-19Initiated Stifel Buy
Oct-17-19Reiterated BofA/Merrill Buy $130 → $135
Oct-01-19Resumed Craig Hallum Buy $127
Sep-26-19Initiated Oppenheimer Outperform $130
Dec-03-21 09:46AM  
Dec-02-21 11:31AM  
05:38AM  
03:00AM  
Dec-01-21 05:05PM  
03:23PM  
05:35AM  
Nov-30-21 03:18PM  
Nov-29-21 06:44AM  
Nov-25-21 09:43AM  
Nov-24-21 11:18AM  
06:50AM  
Nov-23-21 11:03AM  
09:08AM  
Nov-22-21 11:13AM  
Nov-18-21 08:30AM  
Nov-16-21 06:38AM  
Nov-04-21 08:14AM  
Nov-03-21 09:37AM  
06:24AM  
12:31AM  
Nov-02-21 06:25PM  
04:05PM  
Nov-01-21 06:00AM  
Oct-29-21 08:40AM  
Oct-26-21 03:02PM  
Oct-25-21 05:33PM  
Oct-21-21 09:25AM  
Oct-19-21 09:25AM  
Oct-12-21 12:03PM  
Oct-08-21 06:00AM  
Sep-17-21 08:02PM  
Sep-15-21 02:30PM  
Sep-14-21 09:05AM  
Sep-07-21 12:55PM  
Sep-01-21 06:00AM  
Aug-30-21 07:00AM  
Aug-27-21 07:01PM  
11:31AM  
Aug-19-21 09:15AM  
Aug-16-21 06:00AM  
Aug-13-21 09:00AM  
Aug-09-21 01:13PM  
09:02AM  
Aug-06-21 05:50PM  
05:25PM  
Jul-30-21 06:20AM  
Jul-29-21 11:14AM  
02:02AM  
Jul-28-21 05:55PM  
04:42PM  
04:05PM  
Jul-21-21 03:02PM  
Jul-19-21 09:54AM  
05:20AM  
Jul-16-21 11:22AM  
Jul-10-21 06:12AM  
Jul-08-21 06:00AM  
Jul-07-21 08:30AM  
Jul-06-21 11:49AM  
Jun-23-21 12:31PM  
Jun-15-21 02:32PM  
Jun-08-21 05:28AM  
Jun-03-21 11:31AM  
May-26-21 10:00AM  
07:06AM  
06:05AM  
May-25-21 04:47PM  
May-24-21 06:00AM  
May-22-21 09:56AM  
May-21-21 08:00AM  
06:49AM  
May-20-21 04:17PM  
03:51PM  
06:36AM  
May-19-21 05:15PM  
May-18-21 08:05PM  
May-15-21 06:39AM  
May-13-21 07:01AM  
06:16AM  
May-10-21 06:23PM  
May-05-21 08:29AM  
06:01AM  
03:31AM  
May-04-21 06:09PM  
05:25PM  
04:00PM  
03:15PM  
May-03-21 06:00AM  
Apr-28-21 06:00AM  
Apr-25-21 07:00AM  
Apr-22-21 08:31AM  
Apr-14-21 06:00AM  
Apr-12-21 07:26AM  
Apr-08-21 06:00AM  
Apr-06-21 03:56PM  
11:11AM  
Mar-29-21 12:07PM  
Mar-26-21 12:17PM  
Mar-23-21 12:56PM  
Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for breast, prostate, and colon cancers; Oncotype MAP, a tissue test delivering tumor profiling to aid therapy selection for patients with advanced, metastatic, refractory, or recurrent cancer; Oncotype DX AR-V7 Nucleus Detect Test, a liquid-based test for advanced stage prostate cancer; and Covid-19 testing services. The company's pipeline products focus on enhancing the Cologuard test's performance characteristics and developing blood and other fluid-based tests. It has license agreements with MAYO Foundation for Medical Education and Research; and Hologic, Inc. Exact Sciences Corporation was incorporated in 1995 and is headquartered in Madison, Wisconsin.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Conroy Kevin TPresident and CEONov 01Sale93.8816,9221,588,637664,380Nov 03 05:01 PM
Conroy Kevin TPresident and CEOOct 01Sale93.6417,0781,599,184681,302Oct 05 05:26 PM
Conroy Kevin TPresident and CEOSep 01Sale104.4218,9781,981,683698,380Sep 03 04:05 PM
Conroy Kevin TPresident and CEOAug 02Sale107.5019,9702,146,775717,358Aug 04 04:36 PM
Zanotti Katherine SDirectorJul 30Sale111.111,381153,43934,741Aug 02 04:44 PM
Doyle James EdwardDirectorJul 30Sale111.172,640293,48929,830Aug 02 04:42 PM
Elliott Jeffrey ThomasChief Financial OfficerJul 29Sale111.4038,3614,273,530206Aug 02 04:46 PM
Conroy Kevin TPresident and CEOJul 01Sale123.437,784960,779737,328Jul 06 04:01 PM
Condella SarahSVP, Human ResourcesJun 11Option Exercise15.2613,102199,96983,982Jun 14 04:18 PM
Condella SarahSVP, Human ResourcesJun 10Option Exercise5.031,9509,80872,830Jun 11 07:11 PM
Condella SarahSVP, Human ResourcesJun 10Sale120.005,450654,00070,880Jun 11 07:11 PM
Conroy Kevin TPresident and CEOJun 01Sale111.0012,3841,374,624745,112Jun 03 04:11 PM
Conroy Kevin TPresident and CEOMay 03Sale131.0919,2402,522,172757,496May 05 04:49 PM
Conroy Kevin TPresident and CEOApr 01Sale132.3022,7553,010,487776,408Apr 05 04:54 PM
LIDGARD GRAHAM PETERChief Science OfficerMar 11Option Exercise26.0643,2411,126,92681,608Mar 15 04:37 PM
LIDGARD GRAHAM PETERChief Science OfficerMar 11Sale130.0043,2415,621,33038,367Mar 15 04:37 PM
LIDGARD GRAHAM PETERChief Science OfficerMar 08Option Exercise21.684,61299,98838,367Mar 10 05:22 PM
LIDGARD GRAHAM PETERChief Science OfficerMar 05Sale121.3311,7351,423,80833,755Mar 08 05:48 PM
Elliott Jeffrey ThomasChief Financial OfficerMar 03Sale135.022,632355,37338,361Mar 05 04:49 PM
COWARD D SCOTTChief Administrative OfficerMar 03Sale135.022,664359,6931,301Mar 05 04:48 PM
LIDGARD GRAHAM PETERChief Science OfficerMar 02Sale138.422,524349,37245,490Mar 03 08:34 PM
Elliott Jeffrey ThomasChief Financial OfficerMar 02Sale139.244,230588,98940,993Mar 03 08:33 PM
COWARD D SCOTTChief Administrative OfficerMar 02Sale139.234,126574,4573,965Mar 03 08:30 PM
Conroy Kevin TPresident and CEOMar 02Sale138.429,7961,355,962799,163Mar 03 08:28 PM
Condella SarahSVP, Human ResourcesMar 02Sale138.421,679232,40774,052Mar 03 08:27 PM
COWARD D SCOTTChief Administrative OfficerMar 01Option Exercise44.374,175185,2457,241Mar 02 06:56 PM
LIDGARD GRAHAM PETERChief Science OfficerMar 01Option Exercise0.005,025048,014Mar 03 08:34 PM
Elliott Jeffrey ThomasChief Financial OfficerMar 01Option Exercise0.005,025045,223Mar 03 08:33 PM
COWARD D SCOTTChief Administrative OfficerMar 01Option Exercise0.005,02508,091Mar 03 08:30 PM
Conroy Kevin TPresident and CEOMar 01Option Exercise0.0020,5750808,959Mar 03 08:28 PM
Condella SarahSVP, Human ResourcesMar 01Option Exercise0.003,525075,731Mar 03 08:27 PM
LIDGARD GRAHAM PETERChief Science OfficerMar 01Sale137.441,603220,31642,989Mar 02 07:00 PM
Elliott Jeffrey ThomasChief Financial OfficerMar 01Sale136.918,4031,150,48640,198Mar 02 06:59 PM
Condella SarahSVP, Human ResourcesMar 01Sale137.441,098150,90972,206Mar 02 06:58 PM
Conroy Kevin TPresident and CEOMar 01Sale136.8831,2934,283,387788,384Mar 02 06:56 PM
COWARD D SCOTTChief Administrative OfficerMar 01Sale136.965,673776,9833,066Mar 02 06:56 PM
Conroy Kevin TPresident and CEOFeb 26Option Exercise0.009,3120819,677Mar 02 06:56 PM
COWARD D SCOTTChief Administrative OfficerFeb 26Option Exercise0.003,26304,564Mar 02 06:56 PM
WYZGA MICHAEL SDirectorFeb 26Option Exercise26.9810,108272,71421,579Mar 02 07:00 PM
Elliott Jeffrey ThomasChief Financial OfficerFeb 26Option Exercise0.003,437048,601Mar 02 06:59 PM
Condella SarahSVP, Human ResourcesFeb 26Option Exercise0.002,357073,304Mar 02 06:58 PM
LIDGARD GRAHAM PETERChief Science OfficerFeb 26Option Exercise0.003,263044,592Mar 02 07:00 PM
WYZGA MICHAEL SDirectorFeb 26Sale130.1119,0212,474,8222,558Mar 02 07:00 PM
Doyle James EdwardDirectorFeb 26Sale130.112,000260,22030,459Mar 02 06:57 PM
COWARD D SCOTTChief Administrative OfficerFeb 25Sale132.966,788902,5321,301Mar 01 06:10 PM
LIDGARD GRAHAM PETERChief Science OfficerFeb 24Sale136.305,842796,26541,329Feb 25 07:24 PM
COWARD D SCOTTChief Administrative OfficerFeb 24Sale136.306,062826,2518,089Feb 25 07:23 PM
Elliott Jeffrey ThomasChief Financial OfficerFeb 24Sale136.304,449606,39945,164Feb 25 07:24 PM
Conroy Kevin TPresident and CEOFeb 24Sale136.3016,4202,238,046810,365Feb 25 07:22 PM
Condella SarahSVP, Human ResourcesFeb 24Sale136.302,057280,36970,947Feb 25 07:21 PM
COWARD D SCOTTChief Administrative OfficerFeb 23Option Exercise12.8631,600406,50032,901Feb 25 07:23 PM
Elliott Jeffrey ThomasChief Financial OfficerFeb 23Option Exercise0.009,300049,613Feb 25 07:24 PM
Conroy Kevin TPresident and CEOFeb 23Option Exercise0.0034,3250826,785Feb 25 07:22 PM
Condella SarahSVP, Human ResourcesFeb 23Option Exercise0.004,300073,004Feb 25 07:21 PM
LIDGARD GRAHAM PETERChief Science OfficerFeb 23Option Exercise0.0011,575047,171Feb 25 07:24 PM
COWARD D SCOTTChief Administrative OfficerFeb 23Sale136.5118,7502,559,56214,151Feb 25 07:23 PM
ORVILLE JACOB AGeneral Manager, New VenturesFeb 19Sale143.381,696243,1725,445Feb 22 06:01 PM
ORVILLE JACOB AGeneral Manager, New VenturesFeb 18Option Exercise0.003,64907,141Feb 22 06:01 PM
COWARD D SCOTTChief Administrative OfficerFeb 18Sale140.791,980278,7641,301Feb 22 06:00 PM
Elliott Jeffrey ThomasChief Financial OfficerFeb 17Sale142.662,020288,17340,313Feb 18 07:30 PM
COWARD D SCOTTChief Administrative OfficerFeb 17Sale142.661,992284,1793,281Feb 18 07:28 PM
Conroy Kevin TPresident and CEOFeb 17Sale142.6615,8252,257,594792,460Feb 18 07:27 PM
Condella SarahSVP, Human ResourcesFeb 17Sale142.661,033147,36868,704Feb 18 07:25 PM
ORVILLE JACOB AGeneral Manager, New VenturesFeb 17Sale142.661,033147,3683,492Feb 18 07:33 PM
LIDGARD GRAHAM PETERChief Science OfficerFeb 17Sale142.662,131304,00835,596Feb 18 07:31 PM
Elliott Jeffrey ThomasChief Financial OfficerFeb 16Option Exercise0.003,972042,333Feb 18 07:30 PM
COWARD D SCOTTChief Administrative OfficerFeb 16Option Exercise0.003,97205,273Feb 18 07:28 PM
Conroy Kevin TPresident and CEOFeb 16Option Exercise0.0031,1320808,285Feb 18 07:27 PM
Condella SarahSVP, Human ResourcesFeb 16Option Exercise0.002,030069,737Feb 18 07:25 PM
ORVILLE JACOB AGeneral Manager, New VenturesFeb 16Option Exercise0.002,03004,525Feb 18 07:33 PM
LIDGARD GRAHAM PETERChief Science OfficerFeb 16Option Exercise0.003,972037,727Feb 18 07:31 PM
Conroy Kevin TPresident and CEOFeb 05Option Exercise5.7017,54399,995777,153Feb 09 04:34 PM
Conroy Kevin TPresident and CEOFeb 01Sale138.0730,3444,189,596759,610Feb 03 04:20 PM
Conroy Kevin TPresident and CEOJan 04Sale128.7431,8144,095,734825,704Jan 07 09:05 AM
Zanotti Katherine SDirectorDec 14Sale132.0620,0002,641,18221,907Dec 14 06:15 PM